Related Experiment Video
Updated: Feb 4, 2026

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
Published on: September 8, 2021
Ubiquitination and adaptive responses to BRAF inhibitors in Melanoma
Azad Saei1,2, Pieter Johan Adam Eichhorn3,4,5
1Genome Institute of Singapore, ASTAR, Singapore.
Abstract:
Response to targeted therapies is limited by the activation or inhibition of feedback loops. Here we report the ubiquitin specific peptidase 28/F-box WD repeat-containing protein 7 (USP28/FBW7) complex functions as a negative regulator of mitogen-activated protein kinase (MAPK) pathway by targeting v-raf murine sarcoma viral oncogene homolog B (BRAF) for degradation, a process which is lost in a large proportion of BRAF mutant melanoma patients, resulting in resistance to BRAF inhibitor therapies.
Insights
The USP28/FBW7 complex normally degrades BRAF, inhibiting the MAPK pathway. Loss of this function in BRAF mutant melanoma causes resistance to targeted therapies.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Signaling
Background:
- Targeted therapy response is often limited by feedback loops.
- Melanoma harbors frequent BRAF mutations, leading to MAPK pathway activation.
Purpose of the Study:
- To investigate the role of the USP28/FBW7 complex in regulating the MAPK pathway.
- To understand the mechanism of resistance to BRAF inhibitor therapies in melanoma.
Main Methods:
- Investigated the interaction and function of USP28/FBW7 complex.
- Analyzed BRAF protein degradation and MAPK pathway activity.
- Studied melanoma patient samples with BRAF mutations.
Main Results:
- The USP28/FBW7 complex acts as a negative regulator of the MAPK pathway.
- This complex targets BRAF for degradation.
- This degradation mechanism is impaired in many BRAF-mutant melanoma patients.
Conclusions:
- USP28/FBW7-mediated BRAF degradation is crucial for controlling MAPK signaling.
- Loss of this negative feedback loop contributes to BRAF inhibitor resistance in melanoma.
Related Concept Videos
Cells of the Adaptive Immune Response
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Responses to Drought and Flooding
Humoral Immune Responses
Adaptability of Cytoskeletal Filaments
Natural Selection and Adaptation
Beyond physical adaptations,...

